<<

Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids)

Generic Drug Name Brand Name(s) Comments A  B Abacavir Epzicom, Triumeq, Trizivir, Ziagen 9 Orencia 1, 6 ReoPro 1 Verzenio 8 Abiraterone Yonsa, Zytiga 8 Calquence 8 Humira 2 Ado- Kadcyla 2, 8 Gilotrif 8 Agalsidase beta Fabrazyme 1, 2 Albumin 1 Aldesleukin -2, Proleukin 1, 2 Alecensa 8 Amevive 1, 2 Campath. Lemtrada 1 Myozyme 1, 6 Piqray 8 , catheter Cathflo 1, 6 Alteplase, treatment Activase 1, 2 Hexalen 8 Gleolan 2 AMSA PD 8 Amyl Nitrite inhalant Amyl Nitrite 3 Kineret 1 Anastrozole Arimidex 8 Angiotensin II Giapreza 2 Anti-inhibitor coagulant complex Autoplex T, Feiba VH Immuno 5 Atryn 1, 6 Antithrombin III Thrombate 1, 6 Antithymocyte globulin Atgam, Thymoglobulin 1 Antivenin crotalidae (from equine) CroFab 2 Erleada 8 Cinvanti 1, 4 Aripiprazole (injection) Abilify Maintena 2 Trisenox 8 Ayvakit 8 Bavencio 1 Inlyta 8 Vidaza 8 Imuran 9 Bacillus calmette-geurin (bcg) Tice BCG, TheraCys 1

Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System

Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids)

Generic Drug Name Brand Name(s) Comments Simulect 1, 2 BCG Theracys; Tice Vaccine 8 -blmf Blenrep 2, 8 Beleodaq 8 Belrapzo, Bendeka, Treanda 2, 8 Fasenra 1 Benzocaine/tetracaine/butamben Cetacaine 7 Beractant Survanta 1 Avastin, Mvasi 1, 2 Targretin 8 Casodex 8 Durysta 2 Mektovi 8 Angiomax 1, 6 Blenoxane 8 factor products All Blood Factor Products 1, 2 Velcade 2, 8 Bosulif 8 Botulinum toxin-A Botox 1, 6 Botulinum toxin-B Myobloc 1 Adcetris 8 Brexucabtagene autoleucel Tecartus 2 Alunbrig 8 -twza Crysvita 1, 2 injection Busulfex, Myleran 2, 8 C  D C1 esterase inhibitor Berinert, Cinryze, Haegarda 1, 2 Jevtana 2, 8 Cabometyx; Cometriq 8 Calfactant Infasurf 1 Xeloda 8 Cablivi 1, 2 Tabrecta 8 CarBAMazepine Tegretol 9 Paraplatin 8 Kyprolis 8 BiCNU, Gliadel 2, 8 Caspofungin Cancidas 4, 6 -rwlc Libtayo 1, 2 Zykadia 8 Cimzia 1, 2 Cetrotide 9

Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System

Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids)

Generic Drug Name Brand Name(s) Comments Erbitux 1 Leukeran 8 Chloramphenicol Chloromycetin 9 Choriogonadotropin Ovidrel 9 Chorionic Novarel, Pregnyl, Profasi 1 Vistide 9 Platinol-AQ 8 Leustatin; 2-CDA 8 Clolar 2, 8 Cotellic 8 Gloperba 9 Colistimethate Coly-Mycin M 4, 6 Collagenase clostridium histolyticum Xiaflex 2 CONTROLLED SUBSTANCES SCHEDULE CII - CV Security Corticotropin Acthar Gel, H.P. 2 Adakveo 1, 2 Xalkori 8 Crotalidae polyvalent immune fab (ovine) Crofab 2 Cytoxan 2, 8 cycloSPORINE Gengraf, Neoral, Sandimmune 9 liposomal DepoCyt, Vyxeos 2, 8 immune globulin CytoGam 1, 4 Tafinlar 8 DTIC 8 Vizimpro 8 Cosmegen 8 DAPTOmycin Cubicin 1, 4, 6 / Hyaluronidase-fihj Darzalex Faspo 1, 2, 8 Darbepoetin alfa Aranesp 1, 2 Darolutamide Nubeqa 8 Sprycel 8 Cerubidine, Daunomycin 8 DAUNOrubicin, liposomal Daunoxome, Vyxeos 8 Dacogen 2, 8 Degarelix Firmagon 8 Prolia, Xgeva 2 intravitreal implant Ozurdex 2 Zinecard; Totect 9 Digitalis fab Digibind, DigiFab 1, 2 Dihydroergotamine D.H.E. 45, Migranal 9 Dinoprostone vaginal suppository Prostin E2 2 Taxotere 8 Dornase alfa Pulmozyme 1 Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System

Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids)

Generic Drug Name Brand Name(s) Comments Adriamycin 8 DOXOrubicin, liposomal Doxil; Lipodox 2, 8 Imfinzi 1 E  F Soliris 2 Idhifa 8 Enfortunmab vedotin Padcev 1, 2, 8 Rozlytrek 8 Xtandi 8 Ellence 8 Epoetin Epogen, Procrit, Retacrit 1 Epoprostenol Flolan, Veletri 1 Integrelin 1 -jjmr Vyepti 1, 2 Balversa 8 Halaven 8 Tarceva 8 All Trade Names 9 Emcyt, Estracyt 8 All Trade Names 9 Enbrel 1, 6 Ethacrynate injection Edecrin I.V. 2 Toposar; VP 16 8 Etoposide Etopophos 8 Afinitor 8 Aromasin 8 Exenatide Bydureon, Byetta 9 Factor products All Factor Products 1, 2 Fam--nxki Enhertu 1, 2, 8 Fat emulsions Intralipid, Liposyn, Omegaven 1 Inrebic 8 Fibrinogen concentrate (human) Fibryga 1 Granix, Neupogen, Zarxio 1 FUDR 8 Fluconazole Diflucan 9 Fludara 8 intraocular implant Retisert 2 Carac, Fluoroplex, Fluorouracil (5-FU), 8 Efudex, Tolak Eulexin 8 Formaldehyde Formalin 3, 9

Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System

Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids)

Generic Drug Name Brand Name(s) Comments Fosphenytoin Cerebyx 9 Fostamatinib Tavalisse 8 Faslodex 8 G  H Gallium nitrate Ganite 2 Galsulfase Naglazyme 1 Cytovene 9 Ganciclovir ocular implant Vitrasert 2 Iressa 8 Gemzar, Infugem 8 Mylotarg 1, 2, 8 Xospata 8 Givlaari 2 Glatiramer Copaxone 1 Glucagon infusion Glucagon Infusion 2 Simponi Aria 1 Gonadotropin, chorionic Novarel, Pregnyl 9 Goserelin zoladex 8 b immune globulin BayHep B, HyperHEP B, Nabi-HB 1, 4 Herpes zoster vaccine Shingrix, Zostavax 6 Histrelin implant Supprelin LA, Vantas 2, 8 Hydrochloric acid (2N concentrated solution; hydrochloric acid 9 diluted 0.1N, 1.5N, or 0.2N solution; Bernstein test for NG use) HYDROXYprogesterone caproate Makena 2 Hydroxyurea Droxia, Hydrea, Siklos 8 I  L Imbruvica 8 HCL IDArubicin HCL 8 Elaprase 2 Ifex 8 mesylate Gleevec 8 Cerezyme 2 Immune globulin products Carimune, Flebogamma DIF, Gamimune, 2, 4 Gammagard, Gamunex-C Remicade 1, 6 Besponsa 1, 2, 8 alfa-2b Intron A 1, 6 Yervoy 2 Camptosar, Onivyde 8 -irfc Sarclisa 1, 2, 8 Ivabradine Corlanor 9

Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System

Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids)

Generic Drug Name Brand Name(s) Comments Tibsovo 8 Ixempra 2, 8 Ninlaro 8 Lanreotide Somatuline Depot 2 Tykerb 8 Laronidase Aldurazyme 1 Vitrakvi 8 Lenvima 8 Prevymis 1 Femara, Kisqali 8 Leuprolide Eligard, Fensolvi, Lupaneta, Lupron 2, 8 Liraglutide recombinant Victoza 9 Gleostine 8 Lurbinectedin Zepzelca 2, 8 Luspatercept-aamt Reblozyl 1, 2, 9

M  N citrate Citrate of Magnesium 4 Margenza 1, 8 Measles, mumps, rubella vaccine M-M-R II 1, 6 Measles, mumps, rubella, varicella vaccine ProQuad 1, 6 Mechlorethamine Mustargen, Valchlor 8 acetate Provera, Depo-Provera, Depo-SubQ Provera 9 Megace, Megestrol 8 injection Alkeran, Evomela 2, 8 Menotropins Menopur 1, 6, 9 Purinethol, Purixan 8 Otrexup, Rasuvo, Reditrex, Trexall, Xatmep 8 Methylergonovine Methergine 9 Micafungin sodium Mycamine 4, 6 Midostaurin Rydapt 8 MitoMYcin Jelmyto, Mitosol, Mutamycin 2, 8 Lysodren 8 Novantrone 8 -kpkc Poteligeo 1, 2 furoate implant Sinuva 2 -tdfk Lumoxiti 1, 2, 8 Mustargen/aquaphor 0.01% Mustargen/Aquaphor 2 MycophenoLATE mofetil Cellcept 9 Nab- -bound particles Abraxane 8 NARCOTICS ALL NARCOTICS Security Tysabri 1, 2 Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System

Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids)

Generic Drug Name Brand Name(s) Comments Arranon 8 Nerlynx 8 Nevirapine Viramune 9 Tasigna 8 Ofev 8 Zejula 8 Nitroglycerin spray Nitrolingual Spray 3 Norflurane Ease 7 O  P Ocrevus 1 Ocriplasmin ophthalmic Jetrea 2 Octreotide LAR Sandostatin LAR 2, 5 Arzerra 1 Lynparza 8 Lartruvo 1, 8 Omacetaxin Synribo 8 Xolair 1, 6 Onasemnogene Abeparvovec Zolgensma 1, 2 Tagrisso 8 Eloxatin 8 OXcarbazepine Trileptal 9 OXYtocin Pitocin 9 PACLitaxel Taxol 8 Ibrance 8 Kepivance 9 Paliperidone injection Invega Sustenna, Invega Trinza 2 Palivizumab Synagis 1, 2 Pamidronate Aredia 9 Panhematin Hemin 2, 5 Farydak 8 Parenteral Nutrition (PN, TPN) PN, TPN 1 PARoxetine Paxil 9 Pasireotide Signifor 9 Patisiran Onpattro 1, 2 Votrient 8 Oncaspar 1, 2 Neulasta, Udenyca 1, 2 Peginterferon alfa 2a, alfa 2b Pegasys, PEG-Intron 1 Krystexxa 2 Keytruda 1 Alimta 2, 8

Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System

Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids)

Generic Drug Name Brand Name(s) Comments Pemazyre 8 Pentetate trisodium N/A 9 Nipent 2, 8 Perjeta 1, 2, 8 Pertuzumab/Trastuzumab/Hyaluronidase-zzxf Phesgo 1, 2, 8 Turalio 8 Phenol Phenol 3, 8 Dilantin 9 Plerixafor Mozobil 2, 9 Polivy 1, 2, 8 Poliovirus vaccine, inactivated (IPV) IPOL, Kinrix, Pediacel, Pentacel 1 Pomalyst 8 Iclusig 8 Porfimer Photofrin 2 Folotyn 2, 8 Matulane 8 All trade names 9 Propofol Diprivan 1 Proteinase inhibitor (human) Prolastin-C 1,2,4,5 Q  S Quinupristin/dalfopristin Synercid 4, 6 Rabies immune globulin, human HypeRAB 1, 2 RADIOPHARMACEUTICALS ALL RADIOPHARMACEUTICALS SAFETY Lucentis 2 Elitek 1, 6 Ultomiris 1, 2 Stivarga 8 Cinqair 1, 4 Respiratory syncytial virus immune globulin RespiGam 1 Rho d immune globulin RhoGam 1 Virazole, Rebetrol 9 Kisqali 8 Arcalyst 2 Qinlock 8 Risperdal 9 Rituxan, Truxima 1, 2 RiTUXimab / Hyaluronidase Rituxan Hycela 1, 2 Istodax 2, 8 RomiPLOStim Nplate 1, 2 Evenity 1, 2 Rotavirus vaccine, live RotaTeq 1 Rubraca 8

Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System

Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids)

Generic Drug Name Brand Name(s) Comments Jakafi 8 -hziy Trodelvy 1, 2, 8 Leukine 1, 4, 6 Kanuma 1, 2 Koselugo 8 Sylvant 1, 2 Sipuleucel-T Provenge 2, 5 Rapamune 9 -sodium phenylacetate Ammonul 2 Odomzo 8 Nexavar 8 Carospir 9 Streptozocin Zanosar 8 Sutent 8 T  Z Prograf, Protopic 9 Tafasitamab-cxix Monjuvi 1, 2 Tagraxofusp Elzonris 1, 2 Talzenna 8 Talimogene laherparapvec Imlygic 1, 2, 8 Nolvadex 8 Tazemetostat Tazverik 8 Tedizolid Sivextro 4 Temodar 8 Torisel 2, 4, 8 Vumon 8 -trbw Tepezza 1, 2, 9 All trade names 9 Thioguanine Tabloid 8 Thioplex, Thiotepa, Tepadina 2, 8 Thyrotropin alpha recombinant Thyrogen 2 Actemra 1, 4 Hycamtin 8 Toremifene Fareston 8 Yondelis 8 Mekinist 8 Trastuzumab Herceptin, Kanjinti 1, 6, 8 Trastuzumab / Hyaluronidase Herceptin Hylecta, Herzuma, Ogivri, Phesgo 1, 8 Remodulin 1, 2 (All Trans or ATRA) Retin-A, Vesanoid 9 (cream)

Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System

Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids)

Generic Drug Name Brand Name(s) Comments / hydrochloride Lonsurf 8 Triptorelin Trelstar, Triptodur 8 Typhoid vaccine Typhim Vi 1 Stelara 1, 2 listed in next column and any vaccine • Herpes zoster 1, 6 that has been reconstituted by the pharmacy • Measles, mumps, rubella (See also individual listings above) • Measles, mumps, rubella, varicella • Poliovirus vaccine • Rotavirus vaccine • Typhoid vaccine • Varicella • Yellow Valcyte 9 /valproic acid Depakote 9 Valstar 2, 8 Caprelsa 8 Varicella VARIvax 1, 6 VPRIV 2 Zelboraf 8 Venclexta 8 vinBLAStine 8 Vincaspar PFS 8 Navelbine 8 Erivedge 8 Voriconazole Vfend 9 Zolinza 8 Yellow fever vaccine YF-Vax, Stamaril 1, 6 Ziconotide Prialt 2 Retrovir 9 Ziprasidone Geodon 9 Ziv- Zaltrap 8 Reclast, Zometa 9 Zonisamide Zonegran 9

Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System